| |
| |
|
| Insider
Information: |
Neylan John F. |
| Relationship: |
See Remarks |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
35,136 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$35,136 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
35,136 |
|
|
| Total
Value |
$35,136 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -82.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
Chief Medical Officer |
2018-12-12 |
0 |
|
0 |
Premium* |
|
|
Elicio Therapeutics Ord Shs |
ELTX |
See Remarks |
2021-12-20 |
35,136 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-07-24 |
4 |
S |
$7.27 |
$8,826 |
D/D |
(1,214) |
128,030 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-05-01 |
4 |
S |
$5.97 |
$8,603 |
D/D |
(1,441) |
129,244 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-04-24 |
4 |
S |
$5.73 |
$6,928 |
D/D |
(1,209) |
130,685 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2017-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
48,750 |
131,894 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-11-15 |
4 |
S |
$2.77 |
$3,202 |
D/D |
(1,156) |
148,279 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-10-29 |
4 |
S |
$3.07 |
$3,847 |
D/D |
(1,253) |
149,435 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-08-15 |
4 |
S |
$3.04 |
$3,605 |
D/D |
(1,186) |
150,688 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-07-30 |
4 |
S |
$3.86 |
$4,949 |
D/D |
(1,282) |
151,874 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-05-15 |
4 |
S |
$5.69 |
$6,589 |
D/D |
(1,158) |
153,156 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-04-30 |
4 |
S |
$4.67 |
$6,122 |
D/D |
(1,311) |
154,314 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-04-23 |
4 |
S |
$4.59 |
$5,099 |
D/D |
(1,111) |
155,625 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Medical Officer |
• – – |
2018-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
41,250 |
156,736 |
0 |
- |
|
37 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
